Cervical Cancer Diagnostic Testing Market Report

Global and Region Cervical Cancer Diagnostic Testing Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：211
  • REPORT CODE：GMM919858
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.

    North America accounted for the largest share of the global market, followed by Europe. Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region.

    The report details the trend, potential and market size of Cervical Cancer Diagnostic Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cervical Cancer Diagnostic Testingmarket, defines the market attractiveness level of Cervical Cancer Diagnostic Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cervical Cancer Diagnostic Testing industry, describes the types of Cervical Cancer Diagnostic Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cervical Cancer Diagnostic Testing market and the development prospects and opportunities of Cervical Cancer Diagnostic Testing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cervical Cancer Diagnostic Testing market in Chapter 13.

    By Player:

    • Bionor Pharma

    • ISA Pharmaceuticals

    • Dendreon Corporation

    • F Hoffmann-La Roche

    • Profectus Biosciences

    • Merck

    • Advaxis Immunotherapies

    • Virometix

    • GlaxoSmithKline

    • Inovio Pharmaceuticals

    • Otsuka Pharmaceuticals

    • Hologic

    By Type:

    • Pap Testing

    • HPV Testing

    • Colposcopy

    • Cervical Biopsies

    By End-User:

    • Hospitals

    • Cancer Palliative care clinics

    • Diagnostic centers

    • Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cervical Cancer Diagnostic Testing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cervical Cancer Diagnostic Testing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cervical Cancer Diagnostic Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cervical Cancer Diagnostic Testing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cervical Cancer Diagnostic Testing Market Analysis and Outlook to 2022

    • 7.1 Global Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    • 7.2 United States Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    • 7.3 Europe Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    • 7.4 China Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    • 7.5 Japan Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    • 7.6 India Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    • 7.7 South Korea Cervical Cancer Diagnostic Testing Consumption (2017-2022)

    8 Region and Country-wise Cervical Cancer Diagnostic Testing Market Analysis and Outlook to 2028

    • 8.1 Global Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    • 8.2 United States Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    • 8.3 Europe Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    • 8.4 China Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    • 8.5 Japan Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    • 8.6 India Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    • 8.7 South Korea Cervical Cancer Diagnostic Testing Consumption Forecast (2022-2028)

    9 Global Cervical Cancer Diagnostic Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Cervical Cancer Diagnostic Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pap Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global HPV Testing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Colposcopy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Cervical Biopsies Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cervical Cancer Diagnostic Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Palliative care clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Cervical Cancer Diagnostic Testing Market Outlook by Types and Applications to 2028

    • 10.1 Global Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Pap Testing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global HPV Testing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Colposcopy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Cervical Biopsies Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Palliative care clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cervical Cancer Diagnostic Testing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cervical Cancer Diagnostic Testing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cervical Cancer Diagnostic Testing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cervical Cancer Diagnostic Testing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cervical Cancer Diagnostic Testing Market Competitive Analysis

    • 14.1 Bionor Pharma

      • 14.1.1 Bionor Pharma Company Details

      • 14.1.2 Bionor Pharma Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bionor Pharma Cervical Cancer Diagnostic Testing Product and Service

    • 14.2 ISA Pharmaceuticals

      • 14.2.1 ISA Pharmaceuticals Company Details

      • 14.2.2 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Product and Service

    • 14.3 Dendreon Corporation

      • 14.3.1 Dendreon Corporation Company Details

      • 14.3.2 Dendreon Corporation Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Dendreon Corporation Cervical Cancer Diagnostic Testing Product and Service

    • 14.4 F Hoffmann-La Roche

      • 14.4.1 F Hoffmann-La Roche Company Details

      • 14.4.2 F Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-La Roche Cervical Cancer Diagnostic Testing Product and Service

    • 14.5 Profectus Biosciences

      • 14.5.1 Profectus Biosciences Company Details

      • 14.5.2 Profectus Biosciences Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Profectus Biosciences Cervical Cancer Diagnostic Testing Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Cervical Cancer Diagnostic Testing Product and Service

    • 14.7 Advaxis Immunotherapies

      • 14.7.1 Advaxis Immunotherapies Company Details

      • 14.7.2 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Product and Service

    • 14.8 Virometix

      • 14.8.1 Virometix Company Details

      • 14.8.2 Virometix Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Virometix Cervical Cancer Diagnostic Testing Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Cervical Cancer Diagnostic Testing Product and Service

    • 14.10 Inovio Pharmaceuticals

      • 14.10.1 Inovio Pharmaceuticals Company Details

      • 14.10.2 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Product and Service

    • 14.11 Otsuka Pharmaceuticals

      • 14.11.1 Otsuka Pharmaceuticals Company Details

      • 14.11.2 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Product and Service

    • 14.12 Hologic

      • 14.12.1 Hologic Company Details

      • 14.12.2 Hologic Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Hologic Cervical Cancer Diagnostic Testing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cervical Cancer Diagnostic Testing

    • Figure Cervical Cancer Diagnostic Testing Picture

    • Table Global Cervical Cancer Diagnostic Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cervical Cancer Diagnostic Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cervical Cancer Diagnostic Testing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cervical Cancer Diagnostic Testing Consumption by Country (2017-2022)

    • Figure United States Cervical Cancer Diagnostic Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Cervical Cancer Diagnostic Testing Consumption and Growth Rate (2017-2022)

    • Figure China Cervical Cancer Diagnostic Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Cervical Cancer Diagnostic Testing Consumption and Growth Rate (2017-2022)

    • Figure India Cervical Cancer Diagnostic Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cervical Cancer Diagnostic Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Diagnostic Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cervical Cancer Diagnostic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pap Testing Consumption and Growth Rate (2017-2022)

    • Figure Global HPV Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Colposcopy Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Biopsies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Palliative care clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic centers Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Pap Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HPV Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colposcopy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Biopsies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Palliative care clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cervical Cancer Diagnostic Testing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cervical Cancer Diagnostic Testing Export by Region (Top 5 Countries) (2017-2028)

    • Table Bionor Pharma (Foundation Year, Company Profile and etc.)

    • Table Bionor Pharma Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bionor Pharma Cervical Cancer Diagnostic Testing Product and Service

    • Table ISA Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Product and Service

    • Table Dendreon Corporation (Foundation Year, Company Profile and etc.)

    • Table Dendreon Corporation Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dendreon Corporation Cervical Cancer Diagnostic Testing Product and Service

    • Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Cervical Cancer Diagnostic Testing Product and Service

    • Table Profectus Biosciences (Foundation Year, Company Profile and etc.)

    • Table Profectus Biosciences Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Profectus Biosciences Cervical Cancer Diagnostic Testing Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Cervical Cancer Diagnostic Testing Product and Service

    • Table Advaxis Immunotherapies (Foundation Year, Company Profile and etc.)

    • Table Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Product and Service

    • Table Virometix (Foundation Year, Company Profile and etc.)

    • Table Virometix Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Virometix Cervical Cancer Diagnostic Testing Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Cervical Cancer Diagnostic Testing Product and Service

    • Table Inovio Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Product and Service

    • Table Otsuka Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Product and Service

    • Table Hologic (Foundation Year, Company Profile and etc.)

    • Table Hologic Cervical Cancer Diagnostic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Cervical Cancer Diagnostic Testing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US